Latest Prescription Drugs news

Naltrexone Implant Helps HIV Patients Prevent Opioid Relapse

Slow-release implantable naltrexone is associated with better outcomes than the oral drug for HIV-positive patients with an opioid addiction, according to a study published in the April issue of The Lancet HIV.

Parenteral Antimicrobial Tx at Home Burdens Children’s Caregivers

The overall burden of outpatient parenteral antimicrobial therapy is substantially higher than that of oral therapy for caregivers of children on prolonged antimicrobial therapy after hospital discharge, according to a study published in the April issue of Hospital Pediatrics.

Dasotraline Promising for the Treatment of ADHD in Children

Treatment with dasotraline (4 mg/day) significantly improves attention-deficit/hyperactivity disorder symptoms in children aged 6 to 12 years, according to a study published online March 7 in the Journal of Child and Adolescent Psychopharmacology.

FDA Approves Ketamine-Like Drug for Severe Depression

The U.S. Food and Drug Administration on Tuesday approved the nasal spray medication esketamine -- a relative of the club drug and anesthetic ketamine -- for use against severe depression. Sold as Spravato, the fast-acting drug becomes the first new type of medicine approved in years against an illness that affects millions of Americans.